These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11253274)

  • 21. Mutations in PFCRT K76T do not correlate with sulfadoxine-pyrimethamine-amodiaquine failure in Pikine, Senegal.
    Sarr O; Ahouidi AD; Ly O; Daily JP; Ndiaye D; Ndir O; Mboup S; Wirth DF
    Parasitol Res; 2008 Sep; 103(4):765-9. PubMed ID: 18523801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid increase in resistance of Plasmodium falciparum to chloroquine-Fansidar in Uganda and the potential of amodiaquine-Fansidar as a better alternative.
    Sendagire H; Kaddumukasa M; Ndagire D; Aguttu C; Nassejje M; Pettersson M; Swedberg G; Kironde F
    Acta Trop; 2005 Sep; 95(3):172-82. PubMed ID: 16018959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mutant alleles associated to chloroquine and sulfadoxine-pyrimethanime resistance in Plasmodium falciparum of the Ecuador-Peru and Ecuador-Colombia borders].
    Arróspide N; Hijar-Guerra G; de Mora D; Diaz-Cortéz CE; Veloz-Perez R; Gutierrez S; Cabezas-Sánchez C
    Rev Peru Med Exp Salud Publica; 2014 Apr; 31(2):282-7. PubMed ID: 25123867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chemoresistance of Plasmodium falciparum in the urban region of Yaounde, Cameroon. Part 2: Evaluation of the efficacy of amodiaquine and sulfadoxine-pyrimethamine combination in the treatment of uncomplicated Plasmodium falciparum malaria in Yaounde, Cameroon].
    Ringwald P; Keundjian A; Same Ekobo A; Basco LK
    Trop Med Int Health; 2000 Sep; 5(9):620-7. PubMed ID: 11044276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific and nonspecific responses to Plasmodium falciparum blood-stage parasites and observations on the gametocytemia in schoolchildren living in a malaria-endemic area of Mozambique.
    Hogh B; Thompson R; Hetzel C; Fleck SL; Kruse NA; Jones I; Dgedge M; Barreto J; Sinden RE
    Am J Trop Med Hyg; 1995 Jan; 52(1):50-9. PubMed ID: 7856825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of the therapeutic efficacy of amodiaquine versus chloroquine in the treatment of uncomplicated malaria in Abie, Côte-d'Ivoire].
    Adjetey TA; Affoumou GB; Loukou DD; Nebavi NG; Barro-Kiki P; Menan EI; Yavo W; Kone M
    Bull Soc Pathol Exot; 2005 Sep; 98(3):193-6. PubMed ID: 16267959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of sulfadoxine-pyrimethamine in chloroquine resistant falciparum malaria in Bombay.
    Garg MR; Gogtay NJ; Kshirsagar NA
    J Assoc Physicians India; 1996 Oct; 44(10):683-5. PubMed ID: 9251339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of amodiaquine, sulfadoxine-pyrimethamine, and combinations of these drugs for treating chloroquine-resistant falciparum malaria in Hainan Island, China.
    Huang OL; Ouyang WC; Zhou JX; Wu Z; Zhang KY; Huang JK; Cai XZ; Pang XJ; Fu SG; Wang XF
    Bull World Health Organ; 1988; 66(3):353-8. PubMed ID: 3048759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan.
    Durrani N; Leslie T; Rahim S; Graham K; Ahmad F; Rowland M
    Trop Med Int Health; 2005 Jun; 10(6):521-9. PubMed ID: 15941414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unusual pattern of Plasmodium falciparum drug resistance in the northwestern Peruvian Amazon region.
    Durand S; Marquiño W; Cabezas C; Utz G; Fiestas V; Cairo J; Puray M; Lucas C; Salas C; Gutierrez S; Arrospide N; Bacon DJ; Ruebush TK
    Am J Trop Med Hyg; 2007 Apr; 76(4):614-8. PubMed ID: 17426158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chloroquine resistant Plasmodium falciparum malaria in Osogbo Nigeria: efficacy of amodiaquine + sulfadoxine-pyrimethamine and chloroquine + chlorpheniramine for treatment.
    Ogungbamigbe TO; Ojurongbe O; Ogunro PS; Okanlawon BM; Kolawole SO
    Mem Inst Oswaldo Cruz; 2008 Feb; 103(1):79-84. PubMed ID: 18368238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo efficacy study of amodiaquine and sulfadoxine/ pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania.
    Gorissen E; Ashruf G; Lamboo M; Bennebroek J; Gikunda S; Mbaruku G; Kager PA
    Trop Med Int Health; 2000 Jun; 5(6):459-63. PubMed ID: 10929148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response of Plasmodium falciparum to chloroquine and Fansidar in vivo and chloroquine and amodiaquine in vitro in Uganda.
    Nevill CG; Ochen K; Munafu CG; Bekobita D; Sezi CL
    East Afr Med J; 1995 Jun; 72(6):349-54. PubMed ID: 7498001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial.
    Mutabingwa TK; Anthony D; Heller A; Hallett R; Ahmed J; Drakeley C; Greenwood BM; Whitty CJ
    Lancet; 2005 Apr 23-29; 365(9469):1474-80. PubMed ID: 15850631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular surveillance for anti-malarial drug resistance and genetic diversity of Plasmodium falciparum after chloroquine and sulfadoxine-pyrimethamine withdrawal in Quibdo, Colombia, 2018.
    Guerra AP; Olivera MJ; Cortés LJ; Chenet SM; Macedo de Oliveira A; Lucchi NW
    Malar J; 2022 Oct; 21(1):306. PubMed ID: 36307852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the response in vivo and in vitro of Plasmodium falciparum to sulphadoxine-pyrimethamine in the malarious areas of Iran.
    Edrissian GH; Afshar A; Sayedzadeh A; Mohsseni G; Satvat MT
    J Trop Med Hyg; 1993 Aug; 96(4):237-40. PubMed ID: 8345544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The first report of Plasmodium falciparum resistant to chloroquine plus sulphadoxine/pyrimethamine in Rwanda.
    Giboda M; Vanista J; Dastych P
    Trans R Soc Trop Med Hyg; 1988; 82(3):383. PubMed ID: 3068850
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chloroquine and fansidar resistance of Plasmodium falciparum now also in Ghana].
    Kupferschmidt HG; Schröder K; Beltzner B
    Angew Parasitol; 1988 Nov; 29(4):211-3. PubMed ID: 3072886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector.
    Hogh B; Gamage-Mendis A; Butcher GA; Thompson R; Begtrup K; Mendis C; Enosse SM; Dgedge M; Barreto J; Eling W; Sinden RE
    Am J Trop Med Hyg; 1998 Feb; 58(2):176-82. PubMed ID: 9502601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.